GenSight Biologics S.A. (EPA:SIGHT)
0.0734
0.00 (0.00%)
Oct 22, 2026, 5:35 PM CEST
GenSight Biologics Employees
GenSight Biologics had 18 employees as of June 30, 2026. That makes GenSight Biologics the 38,702nd largest employer in the world and 535th in France.
Employees
18
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
€-13,944
Profits / Employee
€852,222
Market Cap
17.21M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Jun 30, 2026 | 18 | - | - | 18 | 0 |
| Dec 31, 2025 | 13 | -3 | -18.75% | 13 | 0 |
| Dec 31, 2024 | 16 | 0 | - | 16 | 0 |
| Dec 31, 2023 | 16 | -29 | -64.44% | 16 | 0 |
| Dec 31, 2022 | 45 | 7 | 18.42% | 45 | 0 |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| genOway Société anonyme | 163 |
| Fermentalg | 64 |
| MaaT Pharma | 60 |
| Biophytis | 19 |
| Aelis Farma | 14 |
| Aton | 13 |
| TME Pharma | 12 |
| Advicenne | 11 |
GenSight Biologics News
- 14 days ago - Gensight Biologics and the 15-20 National Hospital Announce NEJM Publication on GS030 Phase 1/2 Trial Results in Late-Stage Retinitis Pigmentosa - Business Wire
- 15 days ago - GenSight Biologics Announces a Successful €1.0 Million Fundraising Supported by Existing Shareholders - Business Wire
- 15 days ago - GenSight Biologics Reports Cash Position as of September 30, 2026 - Business Wire
- 15 days ago - GenSight Biologics Earnings release: Q3 2026 - Filings
- 23 days ago - GenSight Biologics Reports Interim Financial Results for the First Half of 2026 and Provides Business Updates - Business Wire
- 23 days ago - GenSight Biologics Quarterly report: H1 2026 - Filings
- 23 days ago - GenSight Biologics Earnings release: H1 2026 - Filings
- 6 weeks ago - GenSight Biologics Provides Business Update, Sets Results Date; Stock Up - Nasdaq